Glial cells comprise approximately 90% of the cellular constituency of the adult central nervous system (CNS) and support a vast array of physiological roles essential to CNS function. Yet, the molecular processes that control the initiation of gliogenesis from multipotent neural stem cells in vivo remain poorly understood. Thus, the overriding goal of this proposal is to elucidate the mechanisms that govern the initiation of gliogenesis from neural stem cells. We recently demonstrated that nuclear factor I (NFI) genes control the generation of glial cells in the embryonic spinal cord and are induced in neural stem cell populations coincident with the onset of gliogenesis in vivo. These properties make the NFI genes an ideal starting point from which to investigate the genetic regulatory programs that induce and maintain the early stages of gliogenesis. We, therefore, hypothesize that dissection of both the upstream and downstream events associated with NFI gene regulation will provide novel insights into the molecular control of gliogenesis.
Specific Aims 1 and 2 of this proposal are based on our discovery of two distinct regulators of NFI gene expression in the embryonic spinal cord. Using enhancer screening of the NFIA promoter we have identified a highly conserved enhancer element (e123) that recapitulates the spatial and temporal patterns of NFIA induction when introduced into the embryonic chick spinal cord. Thus, in Aim 1 we propose to exploit e123 as a tool to identify a core set of transcription factors that control NFIA induction. We have also found that bone morphogenic protein (BMP) signaling controls NFI gene expression in the embryonic spinal cord in a manner that is independent of the e123 enhancer studied in Aim 1. Therefore, in Aim 2 we plan to identify BMP-responsive elements in the NFIA promoter, define the specific role of BMP signaling in the regulation of NFI gene expression, and to establish that BMP signaling does indeed operate independently of the transcriptional control mechanisms that regulate e123 induction. Finally, Aim 3 is a logical extension of temporal profiling studies of gene expression in neural stem cells in which we identified a cohort of genes upregulated after NFI gene induction in the embryonic spinal cord. Preliminary studies indicate that four of these genes are sufficient to restore gliogenesis in the absence of NFIA, suggesting that they function downstream of NFI genes. We will use gain- and loss-of function approaches in vivo to discover whether and how these genes promote gliogenesis and function downstream of NFI genes during the initiation of gliogenesis. Upon completion of these studies, we expect to have a much more comprehensive map of molecular processes, both upstream and downstream of NFI genes that control the initiation of gliogenesis during CNS development. The resultant insights into the signals that specify commitment to the glial lineage should lift understanding of glial cell specification in the embryonic spinal cord from the speculative realm to a point where clinical applications can begin to be considered.

Public Health Relevance

This project focuses on the molecular processes that control the generation of glial cells. Glial cells have been implicated in a vast array of cancers and degenerative diseases of the nervous system and understanding the developmental processes that control their generation is a key to developing new therapeutic approaches to these disorders. This proposal is centered around a gene family that controls the generation of glial cells and is also expressed in astrocytomas and contributes to their formation. Thus, the studies herein are directly applicable to the understanding and treatment of astrocytomas.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Neurogenesis and Cell Fate Study Section (NCF)
Program Officer
Owens, David F
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Baylor College of Medicine
Schools of Medicine
United States
Zip Code
Zhu, Wenyi; Krishna, Saritha; Garcia, Cristina et al. (2017) Daam2 driven degradation of VHL promotes gliomagenesis. Elife 6:
Glasgow, Stacey M; Carlson, Jeffrey C; Zhu, Wenyi et al. (2017) Glia-specific enhancers and chromatin structure regulate NFIA expression and glioma tumorigenesis. Nat Neurosci 20:1520-1528
John Lin, Chia-Ching; Yu, Kwanha; Hatcher, Asante et al. (2017) Identification of diverse astrocyte populations and their malignant analogs. Nat Neurosci 20:396-405
Chaboub, Lesley S; Manalo, Jeanne M; Lee, Hyun Kyoung et al. (2016) Temporal Profiling of Astrocyte Precursors Reveals Parallel Roles for Asef during Development and after Injury. J Neurosci 36:11904-11917
Garcia, Isabella; Bhullar, Paramjit K; Tepe, Burak et al. (2016) Local corticotropin releasing hormone (CRH) signals to its receptor CRHR1 during postnatal development of the mouse olfactory bulb. Brain Struct Funct 221:1-20
Lee, Hyun Kyoung; Chaboub, Lesley S; Zhu, Wenyi et al. (2015) Daam2-PIP5K is a regulatory pathway for Wnt signaling and therapeutic target for remyelination in the CNS. Neuron 85:1227-43
Lee, Hyun Kyoung; Laug, Dylan; Zhu, Wenyi et al. (2015) Apcdd1 stimulates oligodendrocyte differentiation after white matter injury. Glia 63:1840-9
Lee, Jun Sung; Xiao, Jiping; Patel, Parita et al. (2014) A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1. Neuro Oncol 16:191-203
Glasgow, Stacey M; Zhu, Wenyi; Stolt, C Claus et al. (2014) Mutual antagonism between Sox10 and NFIA regulates diversification of glial lineages and glioma subtypes. Nat Neurosci 17:1322-9
Gallo, Vittorio; Deneen, Benjamin (2014) Glial development: the crossroads of regeneration and repair in the CNS. Neuron 83:283-308

Showing the most recent 10 out of 19 publications